vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Rapid7, Inc. (RPD). Click either name above to swap in a different company.

CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $217.4M, roughly 1.1× Rapid7, Inc.). Rapid7, Inc. runs the higher net margin — 1.4% vs -35.0%, a 36.5% gap on every dollar of revenue. On growth, Rapid7, Inc. posted the faster year-over-year revenue change (0.5% vs -23.6%). Rapid7, Inc. produced more free cash flow last quarter ($36.4M vs $16.1M). Over the past eight quarters, Rapid7, Inc.'s revenue compounded faster (3.0% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Rapid7, Inc. is a leading global cybersecurity company that offers a full portfolio of solutions including vulnerability management, threat detection and response, cloud security, and security analytics. It serves enterprises, SMBs, and public sector entities across industries like tech, healthcare, finance, and manufacturing worldwide, helping clients address and mitigate cyber risks efficiently.

CCRN vs RPD — Head-to-Head

Bigger by revenue
CCRN
CCRN
1.1× larger
CCRN
$236.8M
$217.4M
RPD
Growing faster (revenue YoY)
RPD
RPD
+24.1% gap
RPD
0.5%
-23.6%
CCRN
Higher net margin
RPD
RPD
36.5% more per $
RPD
1.4%
-35.0%
CCRN
More free cash flow
RPD
RPD
$20.3M more FCF
RPD
$36.4M
$16.1M
CCRN
Faster 2-yr revenue CAGR
RPD
RPD
Annualised
RPD
3.0%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCRN
CCRN
RPD
RPD
Revenue
$236.8M
$217.4M
Net Profit
$-82.9M
$3.1M
Gross Margin
68.9%
Operating Margin
-30.2%
1.0%
Net Margin
-35.0%
1.4%
Revenue YoY
-23.6%
0.5%
Net Profit YoY
-2109.7%
44.1%
EPS (diluted)
$-2.56
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
RPD
RPD
Q4 25
$236.8M
$217.4M
Q3 25
$250.1M
$218.0M
Q2 25
$274.1M
$214.2M
Q1 25
$293.4M
$210.3M
Q4 24
$309.9M
$216.3M
Q3 24
$315.1M
$214.7M
Q2 24
$339.8M
$208.0M
Q1 24
$379.2M
$205.1M
Net Profit
CCRN
CCRN
RPD
RPD
Q4 25
$-82.9M
$3.1M
Q3 25
$-4.8M
$9.8M
Q2 25
$-6.7M
$8.3M
Q1 25
$-490.0K
$2.1M
Q4 24
$-3.8M
$2.2M
Q3 24
$2.6M
$15.4M
Q2 24
$-16.1M
$6.5M
Q1 24
$2.7M
$1.4M
Gross Margin
CCRN
CCRN
RPD
RPD
Q4 25
68.9%
Q3 25
20.4%
70.2%
Q2 25
20.4%
70.6%
Q1 25
20.0%
71.7%
Q4 24
69.5%
Q3 24
20.4%
70.6%
Q2 24
20.8%
70.7%
Q1 24
20.4%
70.3%
Operating Margin
CCRN
CCRN
RPD
RPD
Q4 25
-30.2%
1.0%
Q3 25
-2.4%
2.7%
Q2 25
-2.1%
1.6%
Q1 25
-0.3%
-0.0%
Q4 24
-1.1%
3.4%
Q3 24
0.9%
6.0%
Q2 24
-5.7%
2.5%
Q1 24
0.8%
4.7%
Net Margin
CCRN
CCRN
RPD
RPD
Q4 25
-35.0%
1.4%
Q3 25
-1.9%
4.5%
Q2 25
-2.4%
3.9%
Q1 25
-0.2%
1.0%
Q4 24
-1.2%
1.0%
Q3 24
0.8%
7.2%
Q2 24
-4.7%
3.1%
Q1 24
0.7%
0.7%
EPS (diluted)
CCRN
CCRN
RPD
RPD
Q4 25
$-2.56
$0.05
Q3 25
$-0.15
$0.15
Q2 25
$-0.20
$0.13
Q1 25
$-0.02
$0.03
Q4 24
$-0.13
$0.08
Q3 24
$0.08
$0.21
Q2 24
$-0.47
$0.09
Q1 24
$0.08
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
RPD
RPD
Cash + ST InvestmentsLiquidity on hand
$108.7M
$474.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.8M
$154.7M
Total Assets
$449.0M
$1.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
RPD
RPD
Q4 25
$108.7M
$474.7M
Q3 25
$99.1M
$407.1M
Q2 25
$81.2M
$511.7M
Q1 25
$80.7M
$493.5M
Q4 24
$81.6M
$521.7M
Q3 24
$64.0M
$443.7M
Q2 24
$69.6M
$442.6M
Q1 24
$5.2M
$411.7M
Stockholders' Equity
CCRN
CCRN
RPD
RPD
Q4 25
$322.8M
$154.7M
Q3 25
$408.1M
$127.2M
Q2 25
$412.2M
$90.4M
Q1 25
$418.2M
$52.7M
Q4 24
$419.0M
$17.7M
Q3 24
$424.7M
$-5.1M
Q2 24
$433.3M
$-52.6M
Q1 24
$462.4M
$-86.4M
Total Assets
CCRN
CCRN
RPD
RPD
Q4 25
$449.0M
$1.7B
Q3 25
$538.2M
$1.7B
Q2 25
$553.8M
$1.6B
Q1 25
$576.2M
$1.6B
Q4 24
$589.3M
$1.7B
Q3 24
$597.4M
$1.6B
Q2 24
$602.9M
$1.5B
Q1 24
$648.4M
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
RPD
RPD
Operating Cash FlowLast quarter
$18.2M
$37.6M
Free Cash FlowOCF − Capex
$16.1M
$36.4M
FCF MarginFCF / Revenue
6.8%
16.8%
Capex IntensityCapex / Revenue
0.9%
0.5%
Cash ConversionOCF / Net Profit
12.01×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$146.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
RPD
RPD
Q4 25
$18.2M
$37.6M
Q3 25
$20.1M
$39.0M
Q2 25
$4.2M
$47.5M
Q1 25
$5.7M
$29.8M
Q4 24
$24.2M
$63.8M
Q3 24
$7.5M
$44.0M
Q2 24
$82.4M
$32.9M
Q1 24
$6.0M
$31.1M
Free Cash Flow
CCRN
CCRN
RPD
RPD
Q4 25
$16.1M
$36.4M
Q3 25
$17.9M
$34.8M
Q2 25
$2.3M
$46.6M
Q1 25
$3.8M
$28.4M
Q4 24
$21.7M
$62.6M
Q3 24
$6.3M
$42.6M
Q2 24
$79.6M
$32.6M
Q1 24
$3.8M
$30.4M
FCF Margin
CCRN
CCRN
RPD
RPD
Q4 25
6.8%
16.8%
Q3 25
7.2%
16.0%
Q2 25
0.8%
21.8%
Q1 25
1.3%
13.5%
Q4 24
7.0%
28.9%
Q3 24
2.0%
19.9%
Q2 24
23.4%
15.7%
Q1 24
1.0%
14.8%
Capex Intensity
CCRN
CCRN
RPD
RPD
Q4 25
0.9%
0.5%
Q3 25
0.9%
1.9%
Q2 25
0.7%
0.4%
Q1 25
0.6%
0.6%
Q4 24
0.8%
0.5%
Q3 24
0.4%
0.6%
Q2 24
0.8%
0.1%
Q1 24
0.6%
0.3%
Cash Conversion
CCRN
CCRN
RPD
RPD
Q4 25
12.01×
Q3 25
3.97×
Q2 25
5.70×
Q1 25
14.14×
Q4 24
29.36×
Q3 24
2.92×
2.85×
Q2 24
5.03×
Q1 24
2.23×
22.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

RPD
RPD

Products$209.1M96%
Services$8.2M4%

Related Comparisons